Mariko Nakano

CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant

Matthew G. McDonald, Mark J. Rieder, Mariko Nakano et al. · Molecular Pharmacology · 2009 · 323 citations · Full text

Medicine, Biochemistry, Pharmacology +16

Electrolyzed–Reduced Water Scavenges Active Oxygen Species and Protects DNA from Oxidative Damage

Sanetaka Shirahata, Shigeru Kabayama, Mariko Nakano et al. · Biochemical and Biophysical Research Communications · 1997 · 234 citations

Life Sciences, Biochemistry, Molecular Biology +12

Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase

Mariko Nakano, Edward J. Kelly, Allan E. Rettie · Drug Metabolism and Disposition · 2009 · 158 citations · Full text

Life Sciences, Biochemistry, Genetics +16

Thermodynamics−Structure Relationship of Single Mismatches in RNA/DNA Duplexes

Naoki Sugimoto, Mariko Nakano, Shu‐ichi Nakano · Biochemistry · 2000 · 156 citations

Life Sciences, Biochemistry, Molecular Biology +17

CYP4V2 in Bietti’s Crystalline Dystrophy: Ocular Localization, Metabolism of ω-3-Polyunsaturated Fatty Acids, and Functional Deficit of the p.H331P Variant

Mariko Nakano, Edward J. Kelly, Constanze Wiek et al. · Molecular Pharmacology · 2012 · 110 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +16